Placebo Response in Trials of Negative Symptoms in Schizophrenia: A Critical Reassessment of the Evidence

BACKGROUND: Summarizing evidence from clinical trials of patients with schizophrenia with predominant or prominent negative symptoms (NS), a prior meta-analysis reported a large placebo effect in negative symptoms (Cohen’s d = 2.909). Assuming that such an effect was clinically not plausible, we per...

Descripción completa

Detalles Bibliográficos
Autores principales: Czobor, Pál, Kakuszi, Brigitta, Bitter, István
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673255/
https://www.ncbi.nlm.nih.gov/pubmed/35713342
http://dx.doi.org/10.1093/schbul/sbac061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673255/
https://www.ncbi.nlm.nih.gov/pubmed/35713342
http://dx.doi.org/10.1093/schbul/sbac061

Ejemplares similares